Ace­lyrin crew be­hind first thy­roid eye dis­ease med­i­cine builds its po­ten­tial com­peti­tor, with ear­ly da­ta to boast

Im­munol­o­gy biotech Ace­lyrin an­nounced Wednes­day morn­ing that its ex­per­i­men­tal thy­roid eye dis­ease treat­ment im­proved symp­toms in a small hand­ful of pa­tients as part of an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER